An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients-Reference-Cited by-同舟云学术

An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients

Published:2024-06-07 Issue:9 Volume:61 Page:1185-1194
ISSN:1432-5233
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Fresa Raffaella,Bitterman Olimpia^ORCID,Cavallaro Vincenzo,Di Filippi Marianna,Dimarzo Daniela,Mosca Carmela,Nappi Francesca,Rispoli Marilena,Napoli Angela

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00592-024-02315-z.pdf

Reference49 articles.

1. Grunberger G, Sherr J, Allende M et al (2021) American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract 27(6):505–537

2. Garg SK, Weinzimer SA, Tamborlane WV et al (2017) Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 19(3):155–163

3. Brown SA, Kovatchev BP, Raghinaru D et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381(18):1707–1717

4. Brown SA, Forlenza GP, Bode BW et al (2021) Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. Diabetes Care 44(7):1630–1640

5. Gómez AM, Henao D, Parra D et al (2023) Early and sustained increase in time in range 1 year after initiation of hybrid closed loop therapy via telemedicine in type 1 diabetes patients. Acta Diabetol 60(7):943–949